Skip to content
10-Q

Quarterly Report

ROCK CREEK PHARMACEUTICALS, INC.

0001144204-16-102745

← back to feed
Filed
May 16, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 9, 2016 24.22M sh
Capex Q1 2016 · Mar 31, 2016 $0
Capex Q1 2016 · Mar 31, 2015 $8K
Long Term Debt Q1 2016 · Mar 31, 2016 $4.17M
Long Term Debt Q1 2016 · Dec 31, 2015 $7.52M
Short Term Debt Q1 2016 · Mar 31, 2016 $12.35M
Short Term Debt Q1 2016 · Dec 31, 2015 $12.35M
Cash And Equivalents Q1 2016 · Mar 31, 2016 $552K
Cash And Equivalents Q1 2016 · Dec 31, 2015 $493K
Cash And Equivalents Q1 2016 · Mar 31, 2015 $91K
Cash And Equivalents Q1 2016 · Dec 31, 2014 $395K
Stockholders Equity Q1 2016 · Mar 31, 2016 −$12.03M
Stockholders Equity Q1 2016 · Dec 31, 2015 −$10.65M
Current Liabilities Q1 2016 · Mar 31, 2016 $21.83M
Current Liabilities Q1 2016 · Dec 31, 2015 $22.19M
Total Liabilities Q1 2016 · Mar 31, 2016 $26M
Total Liabilities Q1 2016 · Dec 31, 2015 $29.72M
Current Assets Q1 2016 · Mar 31, 2016 $1.1M
Current Assets Q1 2016 · Dec 31, 2015 $1.04M
Total Assets Q1 2016 · Mar 31, 2016 $13.98M
Total Assets Q1 2016 · Dec 31, 2015 $19.07M
Sga Expense Q1 2016 · Mar 31, 2016 $1.23M
Sga Expense Q1 2016 · Mar 31, 2015 $3.35M
Rd Expense Q1 2016 · Mar 31, 2016 $133K
Rd Expense Q1 2016 · Mar 31, 2015 $473K
Net Income Q1 2016 · Mar 31, 2016 −$2.69M
Net Income Q1 2016 · Mar 31, 2015 −$338K
Operating Income Q1 2016 · Mar 31, 2016 −$1.36M
Operating Income Q1 2016 · Mar 31, 2015 −$3.82M